1 H NMR spectroscopy of plasma glucose was used to resolve the isotopomer contributions from tracer levels of [1,6- 
C 2 ]glucose, a novel tracer of glucose carbon skeleton turnover, and [U- 13 C]propionate, a tracer of hepatic citric acid cycle metabolism. This allowed simultaneous measurements of hepatic glucose production and citric acid cycle fluxes from the NMR analysis of a single plasma glucose sample in fasted animals. Glucose carbon skeleton turnover, as reported by the dilution of [1,6-13 C 2 ]glucose, was 56 ؎ 2 mol/kg/min in the presence of labeling from [U- 13 C]propionate and 53 ؎ 4 mol/kg/min in its absence. Therefore, as expected, the labeling contributions from [U- 13 C]propionate metabolism did not have a significant effect on the measurement of glucose turnover. For the group infused with both tracers, citric acid cycle flux estimates from the analysis of glucose C2 isotopomer ratios were consistent with those from our recent experiments where only [U- 13 C]propionate was infused, verifying that the presence of [1,6-13 C 2 ]glucose did not interfere with these measurements. This integrated analysis of hepatic glucose output and citric acid cycle fluxes from plasma glucose isotopomers yielded a noninvasive estimate of hepatic citrate synthase flux of 74 ؎ 12 mol/kg/min for 24-h fasted rats. © 1998 Academic Press A continual supply of glucose is essential for the proper function of many tissues and organs, notably erythrocytes and the brain. Because of this central role of glucose in energy metabolism and its relevance to a broad range of disease states, numerous methods have been developed to measure the rate of whole-body glucose metabolism and synthesis (1) (2) (3) (4) (5) (6) (7) (8) (9) . These methods assume a constant freely exchanging pool of glucose in the body and a constant rate of glucose synthesis which is balanced by an equal rate of utilization. Since glycolysis is responsible for the bulk of whole-body glucose metabolism, tracers of glucose utilization are usually designed with this pathway in mind (3, 8 -10) . Because there are several substrate cycles that interconvert plasma glucose with glycolytic intermediates, the glucose tracer must be irreversibly degraded by glycolysis to report a true dilution by endogenous glucose production. Since glucose metabolism is usually defined as the glycolytic cleavage of the hexose carbon skeleton, tracers are selected to reflect glucose metabolism to the level of aldolase or below. Classical radioisotope tracers of glucose turnover, [3- 3 H]-, [5-3 H]-, and [6-3 H]glucose are all degraded at or below the level of triose phosphates, and the same is true for their stable deuterated counterparts. [U-
13
C 6 ]Glucose is a true carbon skeleton tracer and is increasingly being used for whole-body glucose utilization measurements (2, 3, 7, 11) .
In addition to direct infusion of a tracer, plasma glucose can also be labeled by metabolism of a labeled gluconeogenic precursor such as lactate or propionate (12) (13) (14) (15) (16) (17) (18) . The labeling pattern in carbons 1, 2, and 3 of glucose reflect that of the labeled phosphoenolpyruvate (PEP) 1 precursor, providing flux information on the component pathways of PEP production from the hepatic citric acid cycle (13, 16, 18) . If the labeling in glucose derived from PEP can be distinguished from the labeling in glucose used for measuring glucose utilization, the components of gluconeogenic flux as well as total glucose output can be measured from a single blood sample. One approach previously used was to choose a stable isotope for one of the tracers and a radioactive tracer for the other (13) , but radioactive tracers cannot be used for routine human clinical studies. Using stable isotopes for tracing both pathways presents a significant analytical challenge for separating the contribution of each pathway. Deuteration and 13 C enrichments of glucose can be measured in a single plasma glucose sample by GC/MS, allowing contributions from separate 13 C-and 2 H-tracers to be resolved (11, 19, 20) . However, these methods require considerable analytical expertise since they involve synthesis of different glucose derivatives whose mass isotopomer distributions must then be subtracted from one another.
FIG. 1.
13 C NMR spectra of plasma glucose obtained from 2 ml of blood taken from a rat infused with 96% [1,6-13 C 2 ]glucose plus unlabeled propionate (a) and a rat infused with [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose plus [U- 13 C]propionate (b). Spectra (a) and (b) represent the sum of 256 and 2000 free-induction decays, respectively. In the insets, S, singlet resonance; D16, doublet from coupling of carbon 1 with carbon 6; D12, doublet from coupling of carbon 1 with neighboring carbon 2; D23, doublet arising from the coupling of carbon 2 with neighboring carbon 3; Q, doublet of doublets, or quartet, arising from coupling of carbon 2 with both its neighbors.
Here we present an alternative approach for simultaneously measuring hepatic glucose production and citric acid cycle metabolism by a simple NMR analysis of plasma glucose using a novel tracer of glucose carbon turnover, [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose, in combination with a uniformly enriched gluconeogenic substrate, [U- C]glucose) interfere with the numerous multiply enriched glucose isotopomers generated from metabolism of [U- 13 C] propionate. Since the connectivity between carbons 1 and 6 is detectable by 13 C NMR, (21) this provides a basis for measuring the amount of intact [1,6-13 C 2 ]glucose within the complex isotopomer mixture.
METHODS
Rats weighing 250 -300 g were fasted for 24 h, and the jugular vein was cannulated under ketamine/xylazine anesthesia. Animals were then infused for 120 min with an aqueous mixture of propionate and 96% [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-glucose (25.00 and 2.75 mol/Kg/min, respectively) following a prime of 20 mol 96% [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose (Cambridge Isotopes, Cambridge, MA). This amount represents about 11% of the rat's caloric requirement over duration of the infusion (22); 9% from propionate and 2%
FIG. 2.
1 H NMR spectrum of a plasma glucose extract obtained from a rat infused with [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose plus unlabeled propionate. Spectrum represent the sum of 32 free-induction decays. The H1␣ signal is expanded below (a), and for comparison, an expanded H1␣ signal of a sample obtained from a rat infused with both tracers is also shown (b). 12 C]propionate (n ϭ 6). At the end of the infusion, 2 ml of blood was drawn from the carotid artery and the animal was sacrificed. Blood was immediately centrifuged and the plasma was deproteinized with perchloric acid. Following neutralization by KOH, the plasma extract was desalted using a mixed-bed ion-exchange resin and then lyophilized and redissolved in 600 l D 2 O. Proton decoupled 13 C NMR spectra of extracts were obtained using a 5-mm broadband probe in a Varian Inova 14.1 T spectrometer operating at 150.9 MHz. Citric acid cycle fluxes were calculated from the analysis of the glucose C2 multiplet as previously described (16) . Figure 1a shows the 13 C resonances of glucose from the plasma extract of a rat infused with [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-glucose and unlabeled propionate. The C1␤ resonance of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose is split into a doublet (J C1-C6 ϭ 4.3 Hz) (21) , enabling it to be distinguished from both the background natural-abundance 13 C signal and any [1- 13 C]glucose produced from recycling of the label via the Cori cycle. This pathway does not generate significant levels of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose because of the high dilution by unenriched endogenous carbons. Although carbons 2-5 of glucose can also become labeled following randomization of the 13 C-label by the hepatic citric acid cycle, the dilution is such that there is no significant probability of producing additional multiply enriched glucose isotopomers. As a consequence, the glucose C2␤ resonance does not contain significant contributions from 13 C- 13 C spin-coupled multiplets under these conditions. The 13 C NMR C1␤ resonance of glucose reports the fractional contribution of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose to the subpopulation of glucose molecules enriched in C1 (69% in this instance). The well-resolved H1␣ resonance from the 1 H NMR spectrum of the same sample (Fig. 2a ) reports the fractional contribution of the C1-enriched subpopulation (7% in this instance) to the total glucose pool. Hence, the product of the two measurements (0.69 ϫ 0.07) gives the fractional contribution of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-glucose to the total glucose pool (0.048). This represents a dilution of ϳ20-fold from the 96%-enriched [1,6- C]propionate are infused, the resulting glucose 13 C NMR spectrum is much more complex (Fig. 1b) , reflecting the additional contribution of C1 glucose isotopomers from the gluconeogenic metabolism of [U- 13 C] propionate. Infusion of [U- 13 C]propionate contributed about 5-6% additional 13 C-enrichment to the carbon 1 of glucose. The D16 signal remained well-resolved, with most of the additional signal is in the form of D12 multiplets, representing contributions from 2,3-and 1,2,3-labeled triose units (16) . This would be also true for other uniformly enriched gluconeogenic precursors such as [U- 13 C]lactate (13, 18) . We have previously shown that of the triose phosphate isotopomers generated from [U- 13 C]propionate metabolism, more than 85% are labeled as [2, 3] [3- 13 C]dihydroxyacetone phosphate with all glyceraldehyde 3-phosphate molecules labeled at C3. Given that [3- 13 C]triose phosphate isotopomers make up 15% of the total C3 isotopomer population and a C3 triose phosphate enrichment of 7%, the probability of forming this set of isotopomers will be (0.15 ϫ 0.07) ϫ 0.07 ϭ 0.0735%. This represents about 1/70th (or less than 1.5%) of the plasma [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose enrichment in these experiments. The presence of additional 13 C in position 1 of glucose following gluconeogenic metabolism of [U- 13 C]propionate results in a smaller D16 contribution to the C1␤ resonance in the 13 C NMR spectrum. However, this is balanced by an increase in the fraction of C1-enriched glucose molecules (Fig. 2b) ; hence, the esti- mate of the [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose fraction is consistent with that of the previous experiment.
RESULTS AND DISCUSSION
As expected, hepatic glucose production estimates in animals infused with unlabeled versus labeled propionate was identical (53 Ϯ 4 and 56 Ϯ 2 mol/kg/min). These values are in good agreement with previous measurements of glucose turnover in overnight-fasted rats (8) . In animals where both glucose and propionate tracers were given, isotopomer analysis of the C2 multiplet provided relative gluconeogenic flux measurements. The relative areas of the multiplet components were C2S ϭ 0.24 Ϯ 0.02; C2D12 ϭ 0.45 Ϯ 0.01; C2D23 ϭ 0.09 Ϯ 0.01; and C2Q ϭ 0.23 Ϯ 0.01, yielding the relative flux measurements of anaplerosis, OAApyruvate recycling and net gluconeogenesis shown in Table 1 . These values are similar to those obtained from our recent study where [U- 13 C] propionate was the only tracer provided (16) . This indicates that the presence of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose or its metabolic products did not influence the gluconeogenic flux measurements derived from [U- 13 C]propionate metabolism. In 24-h fasted rats, hepatic glycogen content has been reported to be 0.7-1.3 mol/g liver (5.6 -10.4 mol/275 g rat) (23) . Given a cumulative glucose production of ϳ1850 mol/rat over the 2-h infusion period, the maximal contribution of glycogenolysis over this period is 10.6/1850, or 0.57% of the total glucose turnover. Based on substrate balance studies, the maximal contribution of glycerol to hepatic glucose output in 24-h fasted rats is about 5% (24) . Since the citric acid cycle is supplying the remaining 90 -95% of glucose carbons, glucose turnover (expressed as triose units) is a good approximation for the absolute rate of PEP synthesis from the hepatic citric acid cycle. Combining this information with the isotopomer output from the glucose C2 analysis provides absolute flux estimates for hepatic anaplerosis, combined recycling through pyruvate kinase, malic enzyme, and Cori cycle (PK ϩ ME ϩ CC) and citrate synthase pathways (see Table 1 ).
The practical lower limit of [1,6-13 C 2 ]glucose quantitation by NMR in a clinically relevant sample was tested with a set of standards consisting of known mixtures of natural-abundance and 99% [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-glucose fraction. The amount of glucose (12.5 mol) represents a typical amount extracted from a 10-ml human blood sample following centrifugation, deproteinization, and lyophilization (Jones et al., unpublished observations). Figure 3 shows the 13 C and 1 H NMR spectra of C1␤ and H1␣ glucose resonances for these samples. Acceptable signal-to-noise levels were achieved with [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose fractions ranging from 0.25 to 2.50% using a total collection time of under 2.5 h per sample (ϳ2 h for the 13 C NMR spectrum and ϳ15 min for the 1 H NMR spectrum). The data provide a precise and accurate correlation between the experimentally measured and real [1,6-13 C 2 ]-glucose fraction (Fig. 4) . The 0.5% enrichment level can be attained in a 70-kg human with a basal glucose turnover of 2 mg/kg/min using a total of ϳ170 mg [1,6-13 C 2 ]glucose (0.01 mg/min/kg infusion for 3 h following a prime of 40 mg).
Quantitation of tracer levels of [U- C]glucose by 13 C NMR in human subjects was demonstrated almost 10 years ago by Brainard et al. (25) . Despite this, NMR has not been widely used for glucose turnover measurements with this tracer because the parent mϩ6 tracer molecule can be reliably quantitated by GC-MS, a less expensive and more sensitive method. For the mϩ6 measurement, positional isotopomer information is redundant; hence, the advantages of 13 C NMR in determining positional labeling information are nullified. However, for accurately determining the composition of a complex mixture of glucose isotopomers that contain fewer than six 13 C-atoms, positional information is crucial. GC-MS methods extract positional information by systematic fragmentation of the molecule and analysis of the constituent mass isotopomers. This approach is very challenging for the analysis of glucose 13 C-isotopomers since it involves the preparation and mass isotopomer analysis of multiple derivatives (26) . In contrast, most 13 C NMR measurements have focused on the quantitation of local clusters of positional isotopomers, such as the triose units of glucose, by taking advantage of nearest-neighbor 13 C- 13 C-spinspin coupling (16, (27) (28) (29) . Consideration of long-range coupling interactions significantly expands the number of different 13 C-isotopomers that can be quantitated by NMR, providing the opportunity to design more complex and informative labeling experiments. 
